Apoptotic cell death in the mouse retinal ganglion cell layer is induced in vivo by the excitatory amino acid homocysteine

Experimental Eye Research

Volumn 73, Issue 1, 2001, Pages 45-57

  Moore, Pamela ^a   El sherbeny, Amira ^a   Roon, Penny ^a   Schoenlein, Patricia V ^a   Ganapathy, Vadivel ^a   Smith, Sylvia B ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Apoptosis; Excitatory amino acids; Glutamate; Homocysteine; Mouse; Retinal ganglion cells

Indexed keywords

BUFFER; CASPASE 3; EXCITATORY AMINO ACID; GLUTAMIC ACID; HOMOCYSTEINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOSPHATE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETIC RETINOPATHY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MICROSCOPY; MORPHOMETRICS; MOUSE; NICK END LABELING; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA; RETINA GANGLION CELL;

EID: 0034775253     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1006/exer.2001.1009     Document Type: Article

References (54)

1. Differential changes in the content of amino acid neurotransmitters in discrete regions of the rat brain prior to the onset and during the course of homocysteine-induced seizures
2. Severe retinopathy in type 1 diabetic patients is not related to the level of plasma homocysteine
3. Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy
4. Neural apoptosis in the retina during experimental and human diabetes: Early onset and effect of insulin
5. Cerebral metabolic and circulatory changes in the rat during seizures induced by DL-homocysteine
6. Diabetic retinopathy
7. Diabetic retinopathy viewed as a neurosensory disorder
8. Excitotoxins: A possible new mechanism for the pathogenesis of ischemic retinal damage
9. Apoptosis in the developing visual system
10. Caspase inhibitors block the retinal ganglion cell death following optic nerve transection
11. Homocysteine levels during fasting and after methionine loading in adolescents with diabetic retinopathy and nephropathy
12. Intracellular calcium transients during neuronal death in the developing retina
13. Comparison of oscillatory potential and pattern electroretinogram measures in diabetic retinopathy
14. Early loss of blue-sensitive color vision in patients with type I diabetes
15. Homocysteine signal cascade: Production of phospholipids, activation of protein kinase C. and the induction of c-los and c-myc in smooth muscle cells
16. Ratio of s-nitrosohomocyst(e)ine to homocyst(e)ine or other thiols determines neurotoxicity in rat cerebrocortical cultures
17. Pathogenesis of vascular disease in hyperhomocysteinaemia
18. Retinopathy in animal models of diabetes
19. Identification of programmed cell death in situ via specific labeling of nuclear DNA
20. Ultrastnictural studies on the long-term effects of sodium glutamate on the rat retina
21. Reduced contrast sensitivity may precede clinically observable retinopathy in type I diabetes
22. Hyperhomocystenemia and endothelial dysfunction in IDDM
23. Poor metabolic control, early age at onset, and marginal folate deficiency are associated with increasing levels of plasma homocysteine in insulin-dependent diabetes mellitus. A five-year follow-up study
24. 3H] GABA from rat olfactory bulb
25. Activation of caspase-3 in axotomized rat retinal ganglion cells in vivo
26. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
27. S-nitrosation ameliorates homocysteine-induced neurotoxicity and calcium responses in primary culture of rat cortical neurons
28. Involvement of N-methyl-D-aspartate receptor and free radical in homocysteine-mediated toxicity on rat cerebellar granule cells in culture
29. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema
30. Seizures induced by homocysteine in rats during ontogenesis
31. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy
32. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor
33. The toxic effect of sodium L-glutamate on the inner layers of the retina
34. The toxic effect of sodium glutamate on rat retina: Changes in putative transmitters and corresponding enzymes
35. Hyperhomocysteinemia: A common and easily reversible risk factor of occlusive artherosclerosis
36. Convulsant action of D.L-homocysteic acid and its steroisomers in immature rats
37. Defective homocysteine metabolism as a risk factor for diabetic retinopathy
38. Glutamate-induced retinal degeneration in neonatal mice: Electron microscopy of the acutely evolving lesion
39. Color vision defects in early diabetic retinopathy
40. Development of electroretinographic alterations in streptozotocin-induced diabetes
41. Nitric oxide and ocular blood flow in patients with IDDM
42. Histologic changes in the inner retina of albino rats following intra-vitreal injection of monosodium L-glutamate
43. Contrast sensitivity in diabetics with and without background retinopathy
44. Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry
45. Detection of apoptosis in tissue sections
46. Molecular basis of glutamate toxicity in retinal ganglion cells
47. Inhibition of caspase activity in retinal cell apoptosis induced by various stimuli in vitro
48. The role of vitamins in the pathogenesis and treatment of hyperhomocyst(e)inaemia
49. Moderate hyperhomocystenemia and retinopathy in insulin-dependent diabetes
50. Plasma homocysteine and its determinants in diabetic retinopathy
51. Chronic low-dose glutamate is toxic to retinal ganglion cells; toxicity blocked by memantine
52. Diabetic retinopathy
53. Diabetic retinopathy
54. L-homocysteic acid selectively activates N-methyl-D-aspartate receptors of rat retinal ganglion cells